Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC

Mutual interactions between cancer cells and the tumor microenvironment importantly contribute to the development of tyrosine kinase inhibitor (TKI) resistance in patients affected by EGFR-mutant NSCLC. In particular, immune recognition-associated proteins with impact on tumor cell clearance through...

Descripción completa

Detalles Bibliográficos
Autores principales: Nigro, Annunziata, Ricciardi, Luca, Salvato, Ilaria, Sabbatino, Francesco, Vitale, Monica, Crescenzi, Maria Assunta, Montico, Barbara, Triggiani, Massimo, Pepe, Stefano, Stellato, Cristiana, Casolaro, Vincenzo, Dal Col, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004973/
https://www.ncbi.nlm.nih.gov/pubmed/32082304
http://dx.doi.org/10.3389/fimmu.2019.03135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004973/
https://www.ncbi.nlm.nih.gov/pubmed/32082304
http://dx.doi.org/10.3389/fimmu.2019.03135

Ejemplares similares